Do Not Go Gentle by Kathleen Stock Review – the Case Against Euthanasia

Why It Matters

The book challenges a growing legislative trend, highlighting risks of coercion, cost‑driven decisions, and erosion of patient protections, which could reshape end‑of‑life care worldwide.

Key Takeaways

• Stock opposes state‑sanctioned assisted dying, citing ethical risks.
• Expansions in Canada and Benelux show slippery‑slope potential.
• Inadequate palliative care may drive demand for euthanasia.
• Financial incentives could influence assisted‑death legislation.
• Vulnerable groups risk coercion under broadened euthanasia laws.

Pulse Analysis

The assisted‑dying debate has moved from academic circles into the halls of Parliament, with the UK’s House of Lords considering a bill that would legalise physician‑assisted death for terminal patients. While public polls show roughly 75% support, Kathleen Stock’s Do Not Go Gentle injects a contrarian voice, arguing that legal frameworks can quickly outpace their original intent. By framing the issue as an "institutionalisation of death," Stock forces policymakers to confront the moral weight of codifying a practice that could become a default solution for complex care dilemmas.

International experience offers a cautionary backdrop. Canada’s Medical Assistance in Dying program, initially limited to foreseeable natural death, has broadened to include non‑terminal and mental‑illness diagnoses, while Benelux nations already permit euthanasia for severe psychological suffering. These expansions illustrate a slippery‑slope dynamic: once criteria are set, advocacy groups often push for further relaxations, sometimes extending to minors or those with disabilities. Stock highlights the danger that financial pressures—such as reducing long‑term care costs—might subtly influence legislative momentum, turning compassionate intent into a cost‑saving mechanism.

The practical implications for healthcare systems are profound. Britain’s hospice sector remains fragmented and under‑funded, leaving many patients without reliable palliative support. Stock argues that robust, universally accessible end‑of‑life care could diminish the perceived need for assisted death, preserving patient autonomy without resorting to irreversible measures. As governments worldwide grapple with ageing populations and rising health expenditures, the book’s call for rigorous safeguards and comprehensive care alternatives serves as a timely reminder that ethical policy must balance compassion with protection against coercion.